Novel isoxazolidinone-containing compound as well as preparation method and application thereof
By developing new isoxazolidinone compounds, the problems of existing herbicide resistance to weeds and crop harm are solved, effective herbicide and crop safety for a variety of harmful weeds, and growth regulation performance Pesticide effects.
Patent Information
- Application Number
- CN202310516827.7
- Authority / Receiving Office
- CN · China
- Patent Type
- Applications(China)
- Current Assignee / Owner
- Filing Date
- 2023-05-09
- Publication Date
- 2024-11-12
AI Technical Summary
Existing herbicides are non-selective to weeds, resulting in weed resistance and risk of medicinal harm to crops, making it difficult to achieve the effect of selective weed control.
Develop a novel isoxazolidinone-containing compound and its preparation method. Through specific reaction steps and catalysts, the compound is prepared and used in pesticide compositions. As herbicide, it is economically important to target specific group structures. Monocotyledon and dicotyledon weeds have excellent herbicidal effects.
It has achieved effective weeding for a variety of harmful weeds, and is safe for economically important crop plants, can achieve good control effects at low doses, and has growth regulation performance on crop plants, suitable for selective control and Inhibit undesirable vegetative growth.
Smart Images

Figure CN118930529A_ABST
Abstract
Description
Technical Field
[0001] The invention belongs to the field of herbicides, and specifically relates to a novel isoxazolidinone-containing compound and a preparation method and use thereof. Background Art
[0002] In agriculture, one of the long-term goals is to protect crops from harmful weeds. One way to achieve this goal is to develop selective herbicides that can control weeds without causing damage to the crops to be protected. In recent years, although some genetically modified crops can tolerate non-selective herbicides (such as glyphosate), their use is still limited, and weeds develop resistance after long-term use. Therefore, there is still a need to develop herbicides with selective weed control functions. Summary of the invention
[0003] The present invention provides a compound represented by general formula (I), its stereoisomer, racemate, tautomer, isotope-labeled substance, nitrogen oxide, pharmaceutically acceptable salt, solvate or solvate of a pharmaceutically acceptable salt,
[0004]
[0005] wherein R1, R2, R3, and R4 are the same or different and are independently selected from hydrogen, halogen, C1-C6 alkyl, halogenated C1-C6 alkyl, C1-C6 alkoxy, halogenated C1-C6 alkoxy, nitro, or cyano;
[0006] R5, R6, R7, R8 are the same or different and are independently selected from hydrogen, halogen, C1-C6 alkyl, halogenated C1-C6 alkyl, C1-C6 alkoxy or halogenated C1-C6 alkoxy;
[0007] R9, R 10 are the same or different and are independently selected from hydrogen, halogen, hydroxy, cyano, C1-C6 alkyl, halogenated C1-C6 alkyl, C1-C6 alkoxy, halogenated C1-C6 alkoxy or -OR 13 ;
[0008] R 13 is selected from C1-C6 alkenyl, C1-C6 alkynyl, C1-C6 alkoxy, C1-C6 alkyl, benzyl, C2-C4 acyl, halogenated C2-C4 acyl, benzoyl, C1-C6 alkylcarbamoyl or phenylcarbamoyl;
[0009] R 11 , R 12 The same or different, independently selected from hydrogen, cyano, C1-C6 alkyl or halogenated C1-C6 alkyl, hydroxy C1-C4 alkyl.
[0010] The preferred compounds of the present invention are:
[0011] R1, R2, R3, R4 may be the same or different and are independently selected from hydrogen, halogen, C1-C4 alkyl or halogenated C1-C4 alkyl, C1-C6 alkoxy, halogenated C1-C6 alkoxy, nitro or cyano;
[0012] R5, R6, R7, R8 may be the same or different and are independently selected from hydrogen, halogen, C1-C4 alkyl, halogenated C1-C4 alkyl, C1-C4 alkoxy or halogenated C1-C4 alkoxy;
[0013] R9, R 10 may be the same or different and independently selected from hydrogen, halogen, hydroxyl, cyano, C1-C6 alkyl, halogenated C1-C6 alkyl, C1-C6 alkoxy or -OR 13 ;
[0014] R 13 It may be selected from C1-C6 alkenyl, C1-C6 alkynyl, C1-C6 alkoxy, C1-C6 alkyl, benzyl, C2-C4 acyl, halogenated C2-C4 acyl, benzoyl or C1-C6 alkylcarbamoyl;
[0015] R 11 , R 12 may be the same or different and independently selected from hydrogen, cyano, C1-C6 alkyl, halogenated C1-C6 alkyl, C1-C4 hydroxyalkyl;
[0016] A further preferred compound of the present invention is, in the general formula (I),
[0017] R1, R2, R3, R4 may be the same or different and are independently selected from hydrogen, fluorine, chlorine, bromine, methyl, ethyl, trifluoromethyl or trifluoroethyl;
[0018] R5, R6, R7, R8 may be the same or different and are independently selected from hydrogen, fluorine, chlorine, bromine, methyl, ethyl, trifluoromethyl, trifluoroethyl, methoxy, ethoxy, trifluoromethoxy or trifluoroethoxy;
[0019] R9, R 10 may be the same or different and independently selected from hydrogen, halogen, hydroxyl, cyano, C1-C6 alkyl, C1-C6 alkoxy or -OR 13 ;
[0020] R 13 It may be selected from C1-C6 alkenyl, C1-C6 alkynyl, C1-C6 alkoxy, C1-C6 alkyl, benzyl, C2-C4 acyl, halogenated C2-C4 acyl or C1-C6 alkylcarbamoyl;
[0021] R 11 , R 12 may be the same or different and independently selected from hydrogen, cyano, C1-C4 alkyl or hydroxy C1-C4 alkyl;
[0022] The more preferred compounds of the present invention are, in the general formula (I),
[0023] R1, R2, R3, R4 may be the same or different and are independently selected from hydrogen, fluorine, chlorine, bromine, methyl, ethyl, trifluoromethyl or trifluoroethyl;
[0024] R5, R6, R7, R8 may be the same or different and are independently selected from hydrogen, fluorine, chlorine, bromine, methyl, ethyl, trifluoromethyl, trifluoroethyl, methoxy, ethoxy, trifluoromethoxy or trifluoroethoxy;
[0025] R9, R 10 may be the same or different and independently selected from hydrogen, halogen, hydroxyl, cyano, C1-C6 alkyl, C1-C6 alkoxy or -OR 13 ;
[0026] R 13 It may be selected from C1-C6 alkenyl, C1-C6 alkynyl, C1-C6 alkoxy, C1-C6 alkyl, benzyl, C2-C4 acyl or C1-C6 alkylcarbamoyl;
[0027] R 11 , R 12 may be the same or different and independently selected from hydrogen, cyano, C1-C4 alkyl, C1-C4 haloalkyl, hydroxy C1-C4 alkyl;
[0028] A further preferred compound of the present invention is, in the general formula (I),
[0029] R1, R2, R3, R4 may be the same or different and are independently selected from hydrogen, fluorine, chlorine, bromine, methyl or trifluoromethyl;
[0030] R5, R6, R7, R8 may be the same or different and are independently selected from hydrogen, fluorine, chlorine, bromine, methyl, trifluoromethyl, methoxy or trifluoromethoxy;
[0031] R9, R 10 may be the same or different and independently selected from hydrogen, halogen, hydroxyl, cyano, C1-C6 alkyl, C1-C6 alkoxy or -OR 13 ;
[0032] R 13 It may be selected from C1-C6 alkenyl, C1-C6 alkynyl, C1-C6 alkoxy, C1-C6 alkyl, benzyl, C2-C4 acyl or C1-C6 alkylcarbamoyl;
[0033] R 11 , R 12 may be the same or different and independently selected from hydrogen, methyl, ethyl, propyl or butyl, hydroxymethyl, hydroxyethyl;
[0034] A further preferred compound of the present invention is, in the general formula (I),
[0035] R1, R2, R3, R4 may be the same or different and are independently selected from hydrogen, fluorine, chlorine, bromine or trifluoromethyl;
[0036] R5, R6, R7, R8 may be the same or different and are independently selected from hydrogen, fluorine, chlorine, bromine, methyl or trifluoromethyl;
[0037] R9, R 10 may be the same or different and are independently selected from hydrogen, bromine, chlorine, hydroxyl, cyano, methyl, ethyl, methoxy, ethoxy, isopropoxy, tert-butoxy or -OR 13 ;
[0038] R 13 It can be selected from cyclopropylmethyl, 2-propenyl, 2-butenyl, 2-propynyl, acetyl, chloroacetyl, benzoyl;
[0039] R 11 , R 12 may be the same or different and independently selected from hydrogen, methyl, ethyl, propyl or hydroxymethyl;
[0040] A further preferred compound of the present invention is, in the general formula (I),
[0041] R1 may be hydrogen;
[0042] R2 may be trifluoromethyl;
[0043] R3 may be hydrogen;
[0044] R4 may be selected from hydrogen or chlorine;
[0045] R5 may be selected from hydrogen, fluorine, chlorine or bromine;
[0046] R6 may be hydrogen;
[0047] R7 may be selected from hydrogen, fluorine, chlorine or bromine;
[0048] R8 may be hydrogen;
[0049] R9 may be hydrogen;
[0050] R 10 may be selected from hydrogen, chlorine, bromine or methoxy;
[0051] R11 It can be methyl;
[0052] R 12 It can be methyl, ethyl or hydroxymethyl.
[0053] Some of the compounds of the present invention can be illustrated by the specific compounds described in Table 1, but the present invention is not limited to these compounds.
[0054]
[0055] In the compounds in Table 1, when R1=H, R2=CF3, R3=H, R6=H, and R8=H, the other groups are as shown in the table.
[0056] Table 1
[0057]
[0058]
[0059]
[0060]
[0061]
[0062]
[0063] The present invention also provides a method for preparing the compound represented by the above formula (I), comprising the following steps:
[0064] The compound represented by formula (II) reacts with the compound represented by formula (III) to obtain the compound represented by formula (I);
[0065]
[0066] Among them, R1, R2, R3, R4, R5, R6, R7, R8, R9, R 10 , R 11 , R 12 As defined above; L is selected from a leaving group, such as Cl or Br;
[0067] According to an embodiment of the present invention, the reaction can be carried out in the presence of a base, and the base can be an inorganic base, an organic base, for example, at least one selected from potassium carbonate, sodium carbonate, pyridine, triethylamine, 4-(dimethylamino)pyridine (DMAP) or diisopropylethylamine (DIEA);
[0068] According to an embodiment of the present invention, the reaction is carried out in a solvent, and the solvent is selected from at least one of N,N-dimethylacetamide, N,N-dimethylformamide, tetrahydrofuran, dioxane or toluene;
[0069] According to an embodiment of the present invention, the reaction temperature may be -5 to 100°C, for example 0 to 50°C, such as 15 to 50°C.
[0070] According to an embodiment of the present invention, this reaction obtains a mixture of diastereoisomers, which can be separated by column chromatography. Optically active isoxazolidinones can be obtained by chiral HPLC of suitable precursors or final products, and can also be obtained by enantioselective reactions, for example, by enzymatic ester or amide cleavage reactions or by using chiral auxiliary agents on dipolarophiles, as described by J.Org.Chem.1988,53,2468.
[0071] According to an embodiment of the present invention, a method for preparing a compound represented by formula (II) comprises the following steps:
[0072]
[0073] (1-1) reacting a compound of formula (VI) with a compound of formula (VII) to obtain a compound of formula (V);
[0074] (1-2) reacting the compound of formula (V) with a reducing agent to obtain a compound of formula (IV);
[0075] (1-3) reacting the compound of formula (IV) with a halogenating agent to obtain a compound of formula (II);
[0076] wherein R1, R2, R3, R4, R5, R6, R7, and R8 have the definitions as described above; L1 is selected from a leaving group, such as Cl, Br, I, or F; and L is selected from a leaving group, such as Cl or Br;
[0077] According to an embodiment of the present invention, step (1-1) can be carried out in the presence of a catalyst selected from tetrakis(triphenylphosphine)palladium, palladium acetate or bis(triphenylphosphine)palladium dichloride;
[0078] According to an embodiment of the present invention, step (1-1) can be carried out in the presence of a base, wherein the base is selected from one, two or more of sodium carbonate, potassium carbonate, pyridine, triethylamine or 4-(dimethylamino)pyridine;
[0079] According to an embodiment of the present invention, step (1-1) can be carried out in the presence of a solvent, and the solvent is selected from one, two or more of toluene, tetrahydrofuran, N,N-dimethylformamide or water; the reaction temperature can be 20 to 150°C, for example 50 to 80°C.
[0080] According to an embodiment of the present invention, the reducing agent in step (1-2) is selected from palladium carbon, sodium borohydride, and lithium aluminum hydride; the reaction temperature can be 0 to 100°C, preferably 15 to 50°C.
[0081] According to an embodiment of the present invention, the halogenating agent in step (1-3) can be N-chlorosuccinimide (NCS), N-bromosuccinimide (NBS), bromine or phosphorus tribromide; the reaction temperature can be 0 to 100°C, for example 0 to 50°C.
[0082] According to an embodiment of the present invention, a method for preparing a compound represented by formula (III) comprises the following steps:
[0083]
[0084] (2-1) reacting the compound of formula (VIII) with hydroxylamine or hydroxylamine hydrochloride to obtain the compound of formula (IX);
[0085] (2-2) The compound of formula (IX) undergoes a cyclization reaction with a base to obtain a compound of formula (III);
[0086] Among them, R9, R 10 , R 11 , R 12 Having the definitions as above;
[0087] According to an embodiment of the present invention, step (2-1) can be carried out in the presence of a base, wherein the base is selected from one, two or more of sodium carbonate, potassium carbonate, sodium hydroxide, potassium hydroxide, pyridine or triethylamine; the solvent is selected from one, two or more of toluene, tetrahydrofuran, N,N-dimethylformamide or water; the reaction temperature can be 0 to 100°C, for example 0 to 50°C.
[0088] According to an embodiment of the present invention, step (2-2) can be carried out in the presence of a base, wherein the base is selected from one, two or more of sodium carbonate, potassium carbonate, sodium hydroxide, potassium hydroxide, pyridine or triethylamine; the solvent is selected from one, two or more of toluene, tetrahydrofuran, methanol, ethanol, or water; the reaction temperature can be 10 to 150°C, for example 10 to 80°C.
[0089] According to an embodiment of the present invention, a method for preparing a compound represented by formula (I) comprises the following steps:
[0090]
[0091] (1) a compound of formula (VI) and a compound of formula (VII) undergo a SUZUKI coupling reaction to obtain a compound of formula (V);
[0092] (2) reacting the compound of formula (V) with hydroxylamine or hydroxylamine hydrochloride to obtain a compound of formula (XII);
[0093] (3) reacting the compound of formula (XII) with a reducing agent to obtain a compound of formula (XI);
[0094] (4) reacting the compound of formula (XI) with an acyl chloride to obtain a compound of formula (X);
[0095] (5) Compound (X) is subjected to a cycloaddition reaction in the presence of a base to obtain a compound of formula (I);
[0096] Among them, R1, R2, R3, R4, R5, R6, R7, R8, R9, R 10 , R 11 , R 12 has the above definition; L1 is selected from a leaving group, such as Cl, Br, I or F;
[0097] According to an embodiment of the present invention, step (1) may be carried out in the presence of a catalyst selected from tetrakis(triphenylphosphine)palladium, palladium acetate or bis(triphenylphosphine)palladium dichloride;
[0098] According to an embodiment of the present invention, step (1) can be carried out in the presence of a base, wherein the base is selected from one, two or more of sodium carbonate, potassium carbonate, pyridine, triethylamine or 4-(dimethylamino)pyridine; the solvent is selected from one, two or more of toluene, tetrahydrofuran, N,N-dimethylformamide or water; the reaction temperature can be 20 to 150°C, for example 50 to 80°C.
[0099] According to an embodiment of the present invention, step (2) can be carried out in the presence of a base, wherein the base is selected from one, two or more of an organic base such as triethylamine, pyridine, sodium acetate, or an inorganic base such as sodium bicarbonate; the reaction solvent is selected from an alcohol solvent such as methanol, ethanol or water or a mixture thereof; the reaction temperature can be 0 to 100°C, preferably 15 to 30°C.
[0100] According to an embodiment of the present invention, the reducing agent in step (3) is selected from sodium borohydride and sodium cyanoborohydride; the reaction temperature can be -50 to 500°C, preferably -50 to 0°C.
[0101] According to an embodiment of the present invention, step (4) can be carried out in the presence of a base, wherein the base is selected from one, two or more of an organic base such as triethylamine, pyridine, sodium acetate, or an inorganic base such as sodium hydroxide or potassium hydroxide; the reaction solvent is selected from dichloromethane, 1,2-dichloroethane, toluene, tetrahydrofuran and the like solvents or mixtures thereof; the reaction temperature can be -10 to 100°C, preferably 0 to 30°C.
[0102] According to an embodiment of the present invention, step (5) can be carried out in the presence of a base, wherein the base is selected from one, two or more of an organic base such as triethylamine, pyridine, sodium acetate, or an inorganic base such as sodium hydroxide or potassium hydroxide; the reaction solvent is selected from an alcohol solvent such as methanol, ethanol or water or a mixture thereof; the reaction temperature can be 0 to 100°C, preferably 15 to 30°C.
[0103] According to an embodiment of the present invention, the boronic acid represented by formula (VII) and the halide represented by formula (VI) can be purchased or prepared by oneself.
[0104] The reaction can be referred to in WO2014048827 or WO2006090234.
[0105] The preparation of the compounds of formula (I) and their starting materials herein can be carried out according to the reaction conditions and the selection of starting materials that are suitable in each case, for example, by replacing only one substituent with another substituent according to the invention in a single step, or by replacing multiple substituents with other substituents according to the invention in the same reaction step.
[0106] The pharmaceutically acceptable salt of the compound of formula (I) of the present invention can be prepared by known methods. For example, the salt of the compound of formula (I) can be obtained by treatment with a suitable base. The preparation method is as follows: the compound of formula (I) is reacted with a base such as sodium hydroxide, potassium hydroxide, calcium hydroxide, zinc hydroxide, etc. in a solvent such as water, ether or toluene to conveniently obtain a pharmaceutically acceptable salt of the compound of formula (I).
[0107] The above preparation method can obtain an isomer mixture of the compound of formula (I). If pure isomers are required, they can be separated by conventional methods such as crystallization or chromatography.
[0108] Unless otherwise stated, all of the above reactions are conveniently carried out at atmospheric pressure or at the native pressure of the particular reaction.
[0109] The present invention also provides a pesticide composition, such as a herbicidal composition, which contains as an active ingredient one, two or more of the compound represented by formula (I), its stereoisomers, racemates, tautomers, isotope-labeled substances, nitrogen oxides, pharmaceutically acceptable salts or esters, solvates or solvates of pharmaceutically acceptable salts.
[0110] According to an embodiment of the present invention, the weight percentage of the active ingredient in the composition is 0.1-99.9%, for example, 0.5-99%.
[0111] According to an embodiment of the present invention, the composition further comprises one, two or more agriculturally and / or forestry- and / or hygienically acceptable carriers.
[0112] According to an embodiment of the present invention, the composition may be administered in the form of a preparation.
[0113] For example, the compound represented by formula (I) as an active ingredient is dissolved or dispersed in a carrier or formulated into a formulation so that it is easier to disperse when used as a herbicide.
[0114] According to an embodiment of the present invention, the preparation includes but is not limited to the following forms: granules, wettable powders, oil suspensions, water suspensions, aqueous emulsions, aqueous preparations, emulsifiable concentrates or microcapsules, etc.
[0115] According to an embodiment of the invention, a liquid or solid carrier and optionally a surfactant may be added to the composition.
[0116] The present invention also provides the use of one, two or more of the compound represented by formula (I), its stereoisomers, racemates, tautomers, nitrogen oxides or pharmaceutically acceptable salts thereof as pesticides, such as herbicides. It has excellent weed control efficacy against a wide range of economically important monocotyledonous and dicotyledonous annual harmful plants. The active ingredient also effectively acts on perennial weeds that sprout from rhizomes, rootstocks and other perennial organs and are difficult to control.
[0117] The present invention also provides the use of one, two or more of the compound represented by formula (I), its stereoisomers, racemates, tautomers, isotope-labeled substances, nitrogen oxides, pharmaceutically acceptable salts or esters, solvates or solvates of pharmaceutically acceptable salts in the preparation of pesticides, such as the preparation of herbicides.
[0118] According to an embodiment of the present invention, the effective amount is 10 to 1000 grams per hectare, preferably the effective amount is 20 to 500 grams per hectare.
[0119] The present invention also provides a method for controlling harmful plants, comprising applying an effective amount of a compound represented by formula (I), a stereoisomer, a racemate, a tautomer, an isotope label, a nitrogen oxide, a pharmaceutically acceptable salt or ester, a solvate or a pharmaceutically acceptable salt solvate thereof, or applying the composition to harmful plants (e.g., harmful plants, such as monocotyledonous or dicotyledonous weeds or harmful crop plants), seeds or tubers or other fertile parts (e.g., grains, seeds or asexual propagation bodies, such as tubers or branches with buds) of desired plants, or growth areas (e.g., cultivated areas) of desired plants. The compounds of the present invention can be applied, for example, before sowing (if appropriate, incorporated into the soil), before germination or after germination. Some representative specific examples of monocotyledonous and dicotyledonous weed flora that can be controlled by the compounds of the present invention are as follows, but it is not intended to limit the enumeration to specific species.
[0120] For example, in the case of monocotyledonous harmful plants, the method can be used to control Aegilops, Agropyron, Agrostis, Alopecurus, Apera, Avena, Brachiaria, Bromus, Cenchrus, Commelina, Cynodon, Cyperus, Dactyloctenium, Digitaria, Echinochloa, Eleocharis, Eleusine, Erewors, and agrostis, Eriochloa, Festuca, Fimbristylis, Imperata, Ischaemum, Heteranthera, Leptochloa, Lolium, Monochoria, Panicum, Paspalum, Phalaris, Phleum, Poa, Rottboellia, Sagittaria, Scirpus, Setaria, Sorghum, and Sphenoclea.
[0121] For dicotyledonous weed species, the method can control species such as Abutilon, Amaranthus, Ambrosia, Anoda, Anthemis, Aphanes, Artemisia, Atriplex, Bellis, Bidens, Capsella, Carduus, Cassia, Centaurea, Chenopodium, Cirsium, ium, Convolvulus, Datura, Desmodium, Emex, Erodium, Erysimum, Euphorbia, Galeopsis, Galinsoga, Galium, Geranium, Hibiscus, Ipomoea, Kochia, Lamium, Lepidium idium, Lindernia, Matricaria, Mentha, Mercurialis, Mullugo, Myosotis, Papaver, Pharbitis, Plantago, Polygonum, Portulaca, Ranunculus, Raphanus, Rorippa, Rotala, Rutaceae, mex, Salsola, Senecio, Sesbania, Sida, Sinapis, Solanum, Sonchus, Sphenoclea, Stellaria, Taraxacum, Thlaspi, Trifolium, Urtica, Veronica, Viola, Xanthium.
[0122] The compounds of the invention have excellent herbicidal activity against monocotyledonous and dicotyledonous weeds, but many desired plants or economically important crops are damaged only to a negligible extent, if at all, depending on the structure of the specific compound of the invention and its application rate. Desired plants or economically important crops in this context are, for example, dicotyledonous crops of the genera Arachis, Beta, Brassica, Cucumis, Cucurbita, Helianthus, Daucus, Glycine, Gossypium, Ipomoea, Lactuca, Linum, Lycopersicon, Miscanthus, Nicotiana, The compounds of the invention are particularly suitable for selectively controlling the growth of harmful plants in crop plant species, such as agriculturally useful plants or ornamental plants.
[0123] In addition, the compounds of the invention (depending on their specific chemical structure and the application rate used) also have excellent growth regulating properties for crop plants. They intervene in the metabolism of the plant itself with a regulatory effect and can thus be used to influence plant components in a targeted manner and facilitate harvesting, for example by inducing dehydration and dwarfing growth. In addition, they are generally also suitable for general control and inhibition of undesirable vegetative growth without killing the plant. Inhibition of vegetative growth plays an important role for many monocotyledonous and dicotyledonous crops, for example, by reducing or completely preventing lodging.
[0124] The compounds of formula (I) according to the present invention or their salts are preferably used in economically important useful and ornamental plants, for example cereals such as wheat, barley, rye, oats, millet, rice, cassava and corn, or other crops such as sugar beet, cotton, soybean, rapeseed, potato, tomato, pea and other vegetables.
[0125] The compounds of the formula (I) or salts thereof according to the invention are preferably used as herbicides in crops of useful plants which are resistant or have been made resistant by recombinant means to the phytotoxic effects of herbicides.
[0126] Useful dosage forms include liquids such as solutions (including emulsifiable concentrates), suspensions, emulsions (including microemulsions and / or suspensions), etc., which may optionally be thickened into jelly-like substances. Useful dosage forms also include solids such as dusts, powders, granules, tablets, pills, films, etc., which may be water-dispersible ("wettable") or water-soluble. The active ingredient can be microencapsulated and then made into a suspension or solid dosage form; in addition, the entire dosage form of the active ingredient can also be encapsulated. Encapsulation can control or delay the release of the active ingredient. Sprayable dosage forms can be diluted in a suitable medium, and the spray volume used is about one hundred to several hundred liters per hectare. High-concentration compositions are mainly used as intermediates for further processing.
[0127] Beneficial Effects
[0128] The compounds of formula (I) of the present invention show good activity against various harmful weeds in agriculture or other fields. Moreover, these compounds can achieve good control effects at very low dosages and are safer for wheat than clomazone, so they can be used to prepare herbicides.
[0129] Definition and explanation of terms
[0130] Unless otherwise specified, the definitions of groups and terms recorded in the specification and claims of this application, including their definitions as examples, exemplary definitions, preferred definitions, definitions recorded in tables, definitions of specific compounds in examples, etc., can be arbitrarily combined and combined with each other. The definitions of groups and compound structures after such combinations and combinations should be understood to be within the scope of the specification and / or claims of this application.
[0131] Unless otherwise defined, all technical terms in this document have the same meaning as commonly understood by those skilled in the art to which the subject matter of the claims belongs. Patents, patent applications, and public materials cited in this document are incorporated herein by reference in their entirety. If there are multiple definitions of a term in this document, the definition in this chapter shall prevail.
[0132] The term "halogen" refers to fluorine, chlorine, bromine and iodine.
[0133] The term "C1-C6 alkyl" means a straight chain and branched alkyl group having 1, 2, 3, 4, 5 or 6 carbon atoms. The alkyl group is, for example, methyl, ethyl, propyl, butyl, pentyl, hexyl, isopropyl, isobutyl, sec-butyl, tert-butyl, isopentyl, 2-methylbutyl, 1-methylbutyl, 1-ethylpropyl, 1,2-dimethylpropyl, neopentyl, 1,1-dimethylpropyl, 4-methylpentyl, 3-methylpentyl, 2-methylpentyl, 1-methylpentyl, 2-ethylbutyl, 1-ethylbutyl, 3,3-dimethylbutyl, 2,2-dimethylbutyl, 1,1-dimethylbutyl, 2,3-dimethylbutyl, 1,3-dimethylbutyl or 1,2-dimethylbutyl or the like or isomers thereof.
[0134] The term "C2-C6 alkenyl" is understood to preferably mean a linear or branched monovalent hydrocarbon radical comprising one or more double bonds and having 2, 3, 4, 5 or 6 carbon atoms, for example, 2 or 3 carbon atoms (i.e., C2-C3 alkenyl). It is understood that in the case where the alkenyl comprises more than one double bond, the double bonds may be separated from each other or conjugated. The alkenyl is, for example, vinyl, allyl, (E)-2-methylvinyl, (Z)-2-methylvinyl, (E)-but-2-enyl, (Z)-but-2-enyl, (E)-but-1-enyl, (Z)-but-1-enyl, pent-4-enyl, (E)-pent-3-enyl, (Z)-pent-3-enyl, (E)-pent-2-enyl, (Z)-pent-2-enyl, (E)- Pent-1-enyl, (Z)-pent-1-enyl, hex-5-enyl, (E)-hex-4-enyl, (Z)-hex-4-enyl, (E)-hex-3-enyl, (Z)-hex-3-enyl, (E)-hex-2-enyl, (Z)-hex-2-enyl, (E)-hex-1-enyl, (Z)-hex-1-enyl, isopropenyl, 2-methylprop-2-enyl, 1-methylprop-2-enyl , 2-methylprop-1-enyl, (E)-1-methylprop-1-enyl, (Z)-1-methylprop-1-enyl, 3-methylbut-3-enyl, 2-methylbut-3-enyl, 1-methylbut-3-enyl, 3-methylbut-2-enyl, (E)-2-methylbut-2-enyl, (Z)-2-methylbut-2-enyl, (E)-1-methylbut-2-enyl, (Z)-1-methyl but-2-enyl, (E)-3-methylbut-1-enyl, (Z)-3-methylbut-1-enyl, (E)-2-methylbut-1-enyl, (Z)-2-methylbut-1-enyl, (E)-1-methylbut-1-enyl, (Z)-1-methylbut-1-enyl, 1,1-dimethylprop-2-enyl, 1-ethylprop-1-enyl, 1-propylvinyl, 1-isopropylvinyl.
[0135] The term "C2-C6 alkynyl" is to be understood as preferably meaning a linear or branched monovalent hydrocarbon radical comprising one or more triple bonds and having 2, 3, 4, 5 or 6 carbon atoms, for example 2 or 3 carbon atoms ("C2-C3 alkynyl"). The alkynyl group is, for example, ethynyl, prop-1-ynyl, prop-2-ynyl, but-1-ynyl, but-2-ynyl, but-3-ynyl, pent-1-ynyl, pent-2-ynyl, pent-3-ynyl, pent-4-ynyl, hex-1-ynyl, hex-2-ynyl, hex-3-ynyl, hex-4-ynyl, hex-5-ynyl, 1-methylprop-2-ynyl, 2-methylbut-3-ynyl, 1-methylbut-3-ynyl, 1-methylbut-2-ynyl, 3-methylbut-1-ynyl, 1-ethylprop-2-ynyl, 3-methylpent-4-ynyl, 2-methylpent-4 In some embodiments, the alkynyl group is ethynyl, prop-1-ynyl or prop-2-ynyl. DETAILED DESCRIPTION
[0136] The technical scheme of the present invention will be further described in detail below in conjunction with specific embodiments. It should be understood that the following embodiments are only exemplary descriptions and explanations of the present invention and should not be construed as limiting the scope of protection of the present invention. All technologies implemented based on the above content of the present invention are included in the scope that the present invention is intended to protect.
[0137] Unless otherwise specified, the raw materials and reagents used in the following examples are commercially available or can be prepared by known methods.
[0138] The following chromatographic conditions were used for LC-MS analysis in the following examples:
[0139] Chromatographic column: Agilent ZORBAX SB-C18 150 mm × 4.6 mm, 5 μm (id);
[0140] Detection wavelength: 254 nm; flow rate: 0.8 mL / min; column temperature: 30 °C;
[0141] Gradient elution conditions:
[0142] Time (min) Acetonitrile (%) 0.1 Formic acid aqueous solution (volume %) 0.00 50 50 5.00 50 50 15.00 90 10 25.00 90 10
[0143] Example 1: Preparation of 2-(2-chloro-5-(5-(trifluoromethyl)pyridin-2-yl)benzyl)-4,4-dimethylisoxazolidin-3-one (Compound 1) Preparation of 3-chloro-N-hydroxy-2,2-dimethylpropionamide
[0144]
[0145] At 0°C, add 2.69g (0.039mol) of hydroxylamine hydrochloride and 30ml of water into a flask, and drop 2.84g (0.071mol) of sodium hydroxide aqueous solution. Keep warm for 1h. Warm to room temperature, and add 5.00g (0.032mol) of chloropivaloyl chloride to the above reaction solution. React at room temperature for 5h, and a white solid will be produced. Filter, wash the filter cake with water, and dry to obtain 4.04g of product with a yield of 83%.
[0146] LC-MS [M+H] + =152.05, [M+Na] + =174.03, [M+K] + =190.00
[0147] Preparation of 4,4-dimethylisoxazolidin-3-one
[0148]
[0149] At room temperature, 4.00g (0.026mol) 3-chloro-N-hydroxy-2,2-dimethylpropionamide and 40ml methanol were added to a flask, and 1.16g (0.029mol) sodium hydroxide methanol solution was added to the above mixture. The mixture was reacted at room temperature for 7h, desolventized under reduced pressure, water was added to the concentrate, and dichloromethane (50ml*3) was used for extraction. The organic phases were combined, dried over anhydrous sodium sulfate, filtered, and the filtrate was concentrated under reduced pressure to obtain 2.83g of the product with a yield of 93%.
[0150] LC-MS [M+H] + =116.07, [M+Na] + =138.05, [M+K] + =154.03
[0151] Preparation of 4-fluoro-3-(5-(trifluoromethyl)pyridin-2-yl)benzaldehyde
[0152]
[0153] Under nitrogen protection, 2.72g (0.015mol) 2-chloro-5-trifluoromethylpyridine, 100ml tetrahydrofuran, 30ml water, 0.35g (0.0003mol) tetrakis (triphenylphosphine) palladium, 1.66g (0.012mol) potassium carbonate were added to a three-necked flask at room temperature and stirred for 0.5h. 1.68g (0.01mol) (2-fluoro-5-formylphenyl) boronic acid was slowly added to the above reaction solution. After addition, the reaction was carried out at 60°C for 8h. The reaction solution was cooled to room temperature, filtered, and desolventized under reduced pressure. The concentrated solution was extracted with ethyl acetate (50ml*2), the organic phases were combined, washed once with saturated brine, and dried over anhydrous sodium sulfate. Filter, concentrate the filtrate under reduced pressure, and column chromatography (eluent: ethyl acetate: petroleum ether 1:15) was performed to obtain 1.94g of the product with a yield of 72%.
[0154] LC-MS [M+H] + =270.06, [M+Na] + =292.04, [M+K] + =308.01
[0155] Preparation of (4-fluoro-3-(5-(trifluoromethyl)pyridin-2-yl)phenyl)methanol
[0156]
[0157] At room temperature, add 0.38g (0.010mol) of sodium borohydride and 20ml of tetrahydrofuran to a two-necked flask. Add 1.35g (0.005mol) of 4-fluoro-3-(5-(trifluoromethyl)pyridin-2-yl)benzaldehyde in tetrahydrofuran solution to the above reaction solution. After addition, react at room temperature for 2h. Add water and 1M hydrochloric acid solution to the reaction solution until no more bubbles are generated. Extract with ethyl acetate (30ml*2), combine the organic phases, wash once with saturated brine, and dry over anhydrous sodium sulfate. Filter, and concentrate the filtrate under reduced pressure to obtain 1.36g of the product with a yield of 100%.
[0158] LC-MS [M+H] + =272.07, [M+Na] + =294.05, [M+K] + =310.02
[0159] Preparation of 2-(5-(bromomethyl)-2-fluorophenyl)-5-(trifluoromethyl)pyridine
[0160]
[0161] At 0°C, add 1.36g (0.005mol) (4-fluoro-3-(5-(trifluoromethyl)pyridin-2-yl)phenyl)methanol and 20ml tetrahydrofuran into a flask, and drop 1.42g (0.0053mol) phosphorus tribromide. After the addition, move to room temperature and react for 1.5h. Remove the solvent under reduced pressure, add water, extract with ethyl acetate (30ml*2), combine the organic phases, wash once with saturated brine, and dry over anhydrous sodium sulfate. Filter, and concentrate the filtrate under reduced pressure to obtain 1.56g of the product with a yield of 93%.
[0162] LC-MS [M+H] + =333.99, [M+Na] + =355.97, [M+K] + =371.94
[0163] Preparation of 2-(4-fluoro-3-(5-(trifluoromethyl)pyridin-2-yl)benzyl)-4,4-dimethylisoxazolidin-3-one (Compound 1)
[0164]
[0165] At room temperature, 1.50g (0.0045mol) 2-(5-(bromomethyl)-2-fluorophenyl)-5-(trifluoromethyl)pyridine, 20ml N,N-dimethylformamide, 0.52g (0.0045mol) 4,4-dimethylisoxazolidin-3-one, and 0.75g (0.0054mol) potassium carbonate were added to a flask. The reaction was allowed to proceed for 7h at room temperature. Water was added to the reaction solution, and the mixture was extracted with ethyl acetate (30ml*2). The organic phases were combined, washed once with saturated brine, and dried over anhydrous sodium sulfate. The filtrate was filtered, concentrated under reduced pressure, and subjected to column chromatography (eluent: ethyl acetate: petroleum ether 1:5) to obtain 1.48g of the product with a yield of 89%.
[0166] LC-MS [M+H] + =369.12, [M+Na] + =391.10, [M+K] + =407.07
[0167] 1 H-NMR (400 MHz, solvent CDCl3) δ (ppm): 8.89 (1H, s), 8.42 (1H, d), 7.91 (1H, d), 7.48 (1H, d), 7.42 (1H, t), 7.27 (1H, d), 4.81 (2H, s), 3.99 (2H, s), 1.42 (3H, s), 1.23 (3H, s).
[0168] Example 2: Preparation of 2-(2-chloro-5-(3-chloro-5-(trifluoromethyl)pyridin-2-yl)-4-fluorobenzyl)-4,4-dimethylisoxazolidin-3-one (Compound 169)
[0169] Preparation of 2-chloro-5-(3-chloro-5-(trifluoromethyl)pyridin-2-yl)-4-fluorobenzaldehyde
[0170]
[0171] Under nitrogen protection, 3.2g (0.015mol) 2,3-dichloro-5-trifluoromethylpyridine, 100ml tetrahydrofuran, 30ml water, 0.34g (0.0003mol) tetrakis (triphenylphosphine) palladium, and 1.64g (0.012mol) potassium carbonate were added to a three-necked flask at room temperature and stirred for 0.5h. 2.0g (0.01mol) (4-chloro-2-fluoro-5-formylphenyl) boronic acid was slowly added to the above reaction solution. After addition, the reaction was carried out at 60°C for 8h. The reaction solution was cooled to room temperature, filtered, and desolventized under reduced pressure. The concentrated solution was extracted with ethyl acetate (50ml*2), the organic phases were combined, washed once with saturated brine, and dried over anhydrous sodium sulfate. Filter, concentrate the filtrate under reduced pressure, and column chromatography (eluent: ethyl acetate: petroleum ether 1:15) was performed to obtain 1.43g of the product with a yield of 43%.
[0172] LC-MS [M+H] + =337.98, [M+Na] + =359.96, [M+K] + =375.93
[0173] Preparation of (2-chloro-5-(3-chloro-5-(trifluoromethyl)pyridin-2-yl)-4-fluorophenyl)methanol
[0174]
[0175] At room temperature, add 0.30g (0.008mol) of sodium borohydride and 20ml of tetrahydrofuran to a two-necked flask. Add 1.35g (0.004mol) of 2-chloro-5-(3-chloro-5-(trifluoromethyl)pyridin-2-yl)-4-fluorobenzaldehyde in tetrahydrofuran solution to the above reaction solution. After addition, react at room temperature for 2h. Add water and 1M hydrochloric acid solution to the reaction solution until no more bubbles are generated. Extract with ethyl acetate (30ml*2), combine the organic phases, wash once with saturated brine, and dry over anhydrous sodium sulfate. Filter, and concentrate the filtrate under reduced pressure to obtain 1.36g of the product with a yield of 100%.
[0176] LC-MS [M+H] + =339.99, [M+Na] +=361.97, [M+K] + =377.95
[0177] Preparation of 2-(5-(bromomethyl)-4-chloro-2-fluorophenyl)-3-chloro-5-(trifluoromethyl)pyridine
[0178]
[0179] At 0°C, add 1.36g (0.004mol) (2-chloro-5-(3-chloro-5-(trifluoromethyl)pyridin-2-yl)-4-fluorophenyl) methanol and 20ml tetrahydrofuran into a flask, and add phosphorus tribromide dropwise. After the addition, move to room temperature and react for 1.5h. Remove the solvent under reduced pressure, add water, extract with ethyl acetate (30ml*2), combine the organic phases, wash once with saturated brine, and dry over anhydrous sodium sulfate. Filter, and concentrate the filtrate under reduced pressure to obtain 1.58g of the product with a yield of 98%.
[0180] LC-MS [M+H] + =401.91, [M+Na] + =423.89, [M+K] + =439.86
[0181] Preparation of 2-(2-chloro-5-(3-chloro-5-(trifluoromethyl)pyridin-2-yl)-4-fluorobenzyl)-4,4-dimethylisoxazolidin-3-one (Compound 169)
[0182]
[0183] At room temperature, 1.41g (0.0035mol) 2-(5-(bromomethyl)-4-chloro-2-fluorophenyl)-3-chloro-5-(trifluoromethyl)pyridine, 20ml N,N-dimethylformamide, 0.40g (0.0035mol) 4,4-dimethylisoxazolidin-3-one, and 0.53g (0.0038mol) potassium carbonate were added to a flask. The reaction was carried out at room temperature for 7h. Water was added to the reaction solution, and ethyl acetate (30ml*2) was used for extraction. The organic phases were combined, washed once with saturated brine, and dried over anhydrous sodium sulfate. Filtered, the filtrate was concentrated under reduced pressure, and column chromatography (eluent: ethyl acetate: petroleum ether 1:5) was performed to obtain 1.34g of the product with a yield of 88%.
[0184] LC-MS [M+H] + =437.04, [M+Na] + =459.03, [M+K] + =475.00
[0185] 1H-NMR (400 MHz, solvent CDCl3) δ (ppm): 8.86 (1H, s), 8.06 (1H, s), 7.48 (1H, d), 7.27 (1H, t), 4.85 (2H, s), 4.01 (2H, s), 1.43 (3H, s), 1.24 (3H, s).
[0186] Example 3: Preparation of 2-(2-fluoro-5-(3-chloro-5-(trifluoromethyl)pyridin-2-yl)-4-chlorobenzyl)-4,4-dimethylisoxazolidin-3-one (Compound 181)
[0187] Preparation of 2-fluoro-5-(3-chloro-5-(trifluoromethyl)pyridin-2-yl)-4-chlorobenzaldehyde oxime
[0188]
[0189] 1g (0.003mol) 2-fluoro-5-(3-chloro-5-(trifluoromethyl)pyridin-2-yl)-4-chlorobenzaldehyde, 20ml tetrahydrofuran, 5ml water, 0.25g (0.0036mol) hydroxylamine hydrochloride, 0.34g (0.0041mol) sodium acetate were added to a flask and reacted at room temperature for 6h. The solvent was removed under reduced pressure, water was added to the concentrate, and ethyl acetate (30ml*2) was used for extraction. The organic phases were combined, washed once with saturated brine, dried over anhydrous sodium sulfate, filtered, and the filtrate was concentrated under reduced pressure to obtain 1.03g of the product with a yield of 99%.
[0190] LC-MS [M+H] + =352.99, [M+Na] + =374.97, [M+K] + =390.94
[0191] Preparation of N-(2-fluoro-5-(3-chloro-5-(trifluoromethyl)pyridin-2-yl)-4-chlorobenzyl)hydroxylamine
[0192]
[0193] Add 1g (0.0028mol) of 2-fluoro-5-(3-chloro-5-(trifluoromethyl)pyridin-2-yl)-4-chlorobenzaldehyde oxime and 5ml of trifluoroacetic acid to a flask. Add 0.27g (0.0042mol) of sodium cyanoborohydride in batches at -15°C. Keep the reaction warm for 4h. Remove the solvent under reduced pressure, extract with ethyl acetate (30ml*2), combine the organic phases, wash once with saturated sodium bicarbonate aqueous solution, wash once with saturated brine, dry over anhydrous sodium sulfate, filter, concentrate the filtrate under reduced pressure, and perform column chromatography (eluent: ethyl acetate: petroleum ether 1:5) to obtain 0.74g of the product with a yield of 73%.
[0194] LC-MS [M+H] + =355.00, [M+Na] + =376.98, [M+K] + =392.96
[0195] Preparation of 3-chloro-N-(2-fluoro-5-(3-chloro-5-(trifluoromethyl)pyridin-2-yl)-4-chlorobenzyl)-N-hydroxy-2,2-dimethylpropionamide
[0196]
[0197] 0.7g (0.002mol) of N-(2-fluoro-5-(3-chloro-5-(trifluoromethyl)pyridin-2-yl)-4-chlorobenzyl)hydroxylamine, 15ml of dichloromethane, and 0.19g (0.0024mol) of pyridine were added to a flask. 0.37g (0.0024mol) of chloropivaloyl chloride was added dropwise at 0℃. The mixture was heated to room temperature and reacted for 3h. The mixture was extracted with dichloromethane (20ml*2). The organic phases were combined, washed once with saturated brine, dried over anhydrous sodium sulfate, filtered, and the filtrate was concentrated under reduced pressure. The product was obtained by column chromatography (eluent: ethyl acetate: petroleum ether 1:5) with a yield of 0.81g and a yield of 87%.
[0198] LC-MS [M+H] + =473.02, [M+Na] + =495.00, [M+K] + =510.98
[0199] Preparation of 2-(2-chloro-5-(3-chloro-5-(trifluoromethyl)pyridin-2-yl)-4-fluorobenzyl)-4,4-dimethylisoxazolidin-3-one
[0200]
[0201] At room temperature, 0.80g (0.0017mol) 3-chloro-N-(2-chloro-5-(3-chloro-5-(trifluoromethyl)pyridin-2-yl)-4-fluorobenzyl)-N-hydroxy-2,2-dimethylpropionamide and 20ml methanol were added to a flask, and 0.08g (0.002mol) sodium hydroxide methanol solution was added to the above mixture. The mixture was reacted at room temperature for 3h, desolventized under reduced pressure, extracted with ethyl acetate (50ml*3), the organic phases were combined, dried over anhydrous sodium sulfate, filtered, and the filtrate was concentrated under reduced pressure. Column chromatography (eluent: ethyl acetate: petroleum ether 1:10) was performed to obtain 0.49g of the product with a yield of 83%.
[0202] LC-MS [M+H] + =437.05, [M+Na] + =459.03, [M+K]+ =475.00
[0203] 1 H-NMR: 8.82 (1H, s), 8.08 (1H, s), 7.50 (1H, d), 7.24 (1H, t), 4.75 (2H, s), 3.99 (2H, s), 1.41 (3H, s), 1.22 (3H, s).
[0204] The present invention synthesized the compounds in Table 1 with reference to the method in the above examples:
[0205] Table 2
[0206]
[0207]
[0208]
[0209]
[0210]
[0211]
[0212]
[0213]
[0214]
[0215]
[0216]
[0217]
[0218]
[0219]
[0220]
[0221]
[0222]
[0223]
[0224]
[0225]
[0226]
[0227]
[0228]
[0229] Formulation Examples
[0230] In the following examples, all percentages are by weight and all dosage forms are prepared using conventional methods.
[0231] Embodiment 4:
[0232] In this embodiment, the wettable powder is prepared using the compound of formula (I) above, and the following proportions of ingredients are used for preparation:
[0233] A wettable powder is prepared by mixing 50% of the compound of formula (I), 4.0% of dodecylphenol polyethoxyglycol ether as a wetting agent and dispersant, 6.0% of potassium lignin sulfonate, 8.0% of sodium aluminosilicate, 32.0% of montmorillonite (calcined) as an inert substance, and grinding.
[0234] Embodiment 5:
[0235] In this example, the compound of formula (I) is used to prepare granules, and the following proportions of ingredients are used for preparation:
[0236] Granules are obtained by mixing 70.0% of the compound of formula (I), 5.0% of sodium lauryl sulfate, 10.0% of calcium lignin sulfonate, 10.0% of potassium chloride, 5.0% of polyvinyl alcohol, grinding the mixture and then spraying with water as granulating liquid.
[0237] Embodiment 6:
[0238] In this embodiment, the compound of formula (I) is used to prepare extruded pellets, and the ingredients are prepared in the following proportions:
[0239] Extruded pellets were obtained by mixing 30.0% of the compound of formula (I), 9.0% of anhydrous calcium sulfate, 8.0% of crude calcium lignin sulfonate, 2.0% of sodium alkylnaphthalene sulfonate, 51.0% of calcium / magnesium bentonite.
[0240] Embodiment 7:
[0241] In this embodiment, the compound of formula (I) is used to prepare emulsifiable concentrate, and the composition is prepared in the following proportions:
[0242] An emulsifiable concentrate was obtained by mixing 25.0% of the compound of formula (I), 60% of solvent 150, 5% of polyethylene glycol 400, 3% of Rhodacal 70 / B, and 7% of Rhodameen RAM.
[0243] Embodiment 8:
[0244] In this example, the compound of formula (I) is used to prepare an aqueous suspension, and the following proportions are used for preparation:
[0245] An aqueous suspension is obtained by mixing 30.0% of the compound of formula (I), 5.0% of POE polystyrene phenyl ether sulfate, 1% of xanthan gum, 5% of polyethylene glycol, 1% of triethanolamine, 1% of sorbitol and adding water to 100.0%.
[0246] Biological activity assay
[0247] Embodiment 9:
[0248] 1. Determination of herbicidal activity
[0249] The herbicidal activity of the compounds of the present invention was shown in the following greenhouse test:
[0250] A certain amount of seeds of grass weeds (barnyard grass, crabgrass, multiflora ryegrass, goosegrass, big-spiked alopecuroides, foxtail grass) and broad-leaved weeds (Amaranthus retroflexus, Chenopodium album, zinnia) were sown in pots containing sandy loam and covered with soil. Pre-emergence treatment was carried out 24 hours after sowing; post-emergence treatment required thinning and planting after emergence (grape weeds 15-20 plants / pot, broad-leaved weeds (2-5 plants / pot), grass weeds grew to the 1.5-2 leaf stage, broad-leaved weeds grew to the 2 true leaf stage, and were sprayed with a crawler crop sprayer (designed and produced by Engineer Research Ltd., UK) according to the experimental design dosage (spray pressure 1.95 kg / cm 2 , spray volume 50ml / m 2 , crawler speed 1.48km / h). The test was repeated 3 times. The growth and development of weeds were observed regularly after application, and the control effect of the test agent on weeds was investigated by visual inspection according to the actual situation.
[0251] Grading standard of control effect: 0% means ineffective, 100% means the weeds are completely killed or severely suppressed.
[0252] Some post-emergence test results are as follows (all mass concentrations are based on active ingredients):
[0253] (1) Illustrative Effects of the Compounds of the Examples on Broadleaf Weeds
[0254] At 600 g ai / ha, compounds 1, 2, 3, 4, 5, 6, 7, 8, 9, 10, 11, 12, 13, 14, 15, 16, 17, 18, 19, 20, 21, 22, 23, 24, 25, 26, 27, 28, 29, 30, 31, 32, 33, 34, 35, 36, 37, 38, 39, 40, 41, 42, 43, 44, 45, 46, 47, 48, 49, 50, 51, 52, 53, 54, 55, 56, 57, 58, 59, 60, 61, 62, 63, 64, 65, 66, 67, 68, 69, 70, 71, 72, 73, 74, 75, 76, 77, 78, 79, 80, 81, 82, 83, 84, 85, 86, 87, 88, 89, 90, 91, 92, 93, 94, 95, 96, 97, 98, 99, 100, 101, 102, 103, 104, 105, 106, 107, 108, 109, 110, 111, 112, 113, 114, 115, 116, 117, 118, 119, 120, 121, 122, 123 3, 124, 125, 126, 127, 128, 129, 130, 131, 132, 133, 134, 135, 136, 137, 138, 139, 140, 141, 142, 143, 144, 145, 146, 147, 148, 149, 150, 151, 152, 153, 154, 155, 156, 157, 158, 159, 160, 161, 162, 163, 164, 165, 166, 167, 168, 169, 170, 171, 172 2. The control effects of 173, 174, 175, 176, 177, 178, 179, 180, 181, 182, 183, 184, 185, 186, 187, 188, 189, 190, 191, 192, 193, 194, 195, 196, 197, 198, 199, 200, 201, 202, 203, 204, 205, 206, 207, 208, 209, 210, 211, 212, 213, 214, 215, and 216 on Amaranthus retroflexus, Chenopodium album, and Zinnia truncatum are all higher than 80%.
[0255] At 150 g ai / ha, compounds 1, 2, 4, 5, 6, 7, 9, 10, 13, 15, 17, 18, 21, 24, 25, 29, 30, 35, 37, 40, 45, 50, 51, 54, 61, 67, 70, 73, 74, 75, 76, 77, 78, 79, 80, 81, 82, 83, 84, 85, 87, 93, 97, 101, 102, 105, 109 , 117, 122, 125, 133, 140, 145, 151, 152, 160, 166, 169, 170, 171, 172, 173, 174, 175, 176, 177, 178, 179, 180, 181, 184, 188, 192, 197, 203, 205, 206, 211, and 216 had a protective effect of more than 80% against Amaranthus retroflexus, Chenopodium album, and Zinnia.
[0256] 37.5g At ai / ha, the control effects of compounds 1, 2, 4, 5, 7, 10, 15, 17, 18, 24, 25, 29, 30, 35, 37, 40, 49, 50, 51, 54, 61, 70, 73, 74, 75, 76, 78, 79, 80, 81, 82, 84, 87, 93, 97, 102, 105, 109, 117, 122, 133, 140, 145, 151, 152, 160, 166, 169, 170, 171, 172, 173, 174, 176, 177, 178, 179, 180, 181, 188, 197, 203, 205, and 211 on Amaranthus retroflexus, Chenopodium album and Zinnia truncatum were all higher than 80%.
[0257] (2) Illustrative Control Effects of the Example Compounds on Grass Weeds
[0258] At 600 g ai / ha, compounds 1, 2, 3, 4, 5, 6, 7, 8, 9, 10, 11, 12, 13, 14, 15, 16, 17, 18, 19, 20, 21, 22, 23, 24, 25, 26, 27, 28, 29, 30, 31, 32, 33, 34, 35, 36, 37, 38, 39, 40, 41, 42, 43, 44, 45, 46, 47, 48, 49, 50, 51, 52, 53, 54, 55, 56, 57, 58, 59, 60, 61, 62, 63, 64, 65, 66, 67 7, 68, 69, 70, 71, 72, 73, 74, 75, 76, 77, 78, 79, 80, 81, 82, 83, 84, 85, 86, 87, 88, 89, 90, 91, 92, 93, 94, 95, 96, 97, 98, 99, 100, 101, 102, 103, 104, 105, 106, 107, 108, 109, 110, 111, 112, 113, 114, 115, 116, 117, 118, 119, 120, 121, 122, 123, 124, 125 5, 126, 127, 128, 129, 130, 131, 132, 133, 134, 135, 136, 137, 138, 139, 140, 141, 142, 143, 144, 145, 146, 147, 148, 149, 150, 151, 152, 153, 154, 155, 156, 157, 158, 159, 160, 161, 162, 163, 164, 165, 166, 167, 168, 169, 170, 171, 172, 173, 174, 175 5. The control effects of 176, 177, 178, 179, 180, 181, 182, 183, 184, 185, 186, 187, 188, 189, 190, 191, 192, 193, 194, 195, 196, 197, 198, 199, 200, 201, 202, 203, 204, 205, 206, 207, 208, 209, 210, 211, 212, 213, 214, 215, 216 on barnyard grass, crabgrass, multiflora ryegrass, goosegrass, big-spiked oats and foxtail grass are all higher than 80%.
[0259] At 150 g ai / ha, compounds 1, 2, 3, 5, 7, 8, 9, 11, 13, 14, 17, 18, 19, 22, 25, 29, 30, 34, 37, 40, 45, 49, 52, 53, 61, 63, 67, 70, 73, 74, 75, 76, 77, 78, 79, 80, 81, 82, 83, 84, 85, 89, 97, 101, 102, 105, 109, 117, 122, 133 The control effects of 25, 133, 140, 145, 151, 157, 160, 166, 169, 170, 171, 172, 173, 174, 175, 176, 177, 178, 179, 180, 181, 185, 188, 192, 197, 203, 205, 206, 209, 211, and 216 on barnyard grass, crabgrass, multiflora ryegrass, goosegrass, black foxtail grass, and foxtail grass are all higher than 80%.
[0260] At 37.5 g ai / ha, the control effects of compounds 1, 3, 10, 14, 25, 42, 49, 64, 65, 66, 67, 72, 73, 82, 87, 91, 97, 110, 137, 142, 145, 159, 163, 168, 169, 170, 173, 183, 184, 197, 199, 200, 201, 202, 203, 204, 205, 206, 208, and 211 on barnyard grass, crabgrass, multiflora ryegrass, goosegrass, alopecuroides australis, and foxtail grass were all higher than 80%.
[0261] In addition to the compounds listed above, other exemplary compounds of the present invention have higher control effects on the weeds tested above.
[0262] 2. Test results of exemplary compounds and control agents
[0263] The inventors synthesized a control compound CK1 having a similar structure to isoxazolone, and tested its herbicidal activity, and compared its activity with the example compounds of the present invention. The test results are shown in Table 3 below.
[0264]
[0265] Table 3
[0266]
[0267]
[0268] In addition to the compounds listed in the above table, other exemplary compounds of the present invention have better weed control effects than the control agent. Therefore, the compounds of formula (I) of the present invention show good activity against a variety of harmful weeds in the agricultural field.
[0269] 3. Crop safety
[0270] A certain amount of crop seeds were sown in paper cups with a diameter of 7 cm filled with nutrient soil, covered with 1 cm of soil after sowing, pressed and watered, and cultured in a greenhouse. After germination, seedlings were thinned out and transplanted. When the test crops grew to the required leaf stage (rice 2-3 leaf stage), they were sprayed on the stems and leaves with a crawler crop sprayer (designed and produced by Engineer Research Ltd., UK) according to the designed dosage of the experiment (spray pressure 1.95 kg / cm 2 , spray volume 50ml / m 2 , crawler speed 1.48km / h), the test was repeated 3 times. After the liquid was naturally air-dried, it was placed in a greenhouse and managed according to the conventional method, and the growth and development of the test crops in each treatment were observed, and the safety of the test agent on the test crops was regularly visually inspected.
[0271] Safety grading standard: 0 means no damage to crops, 100 means complete killing or severe suppression of crops. The test results are shown in Table 4.
[0272] Table 4
[0273]
[0274] Indoor safety tests found that compounds 49, 73, 97, 145, 169, 170, and 173 had good safety for soybean, rice, wheat, and corn at pre- and post-emergence doses of 75-300 g ai / ha, especially for wheat and corn.
[0275] The above is an exemplary description of the implementation of the technical solution of the present invention. It should be understood that the protection scope of the present invention is not limited to the above implementation. Any modification, equivalent substitution, improvement, etc. made by those skilled in the art within the spirit and principle of the present invention should be included in the protection scope of the claims of this application.
Claims
1. A compound represented by formula (I), its stereoisomer, racemate, tautomer, isotope-labeled substance, nitrogen oxide, pharmaceutically acceptable salt, solvate or solvate of a pharmaceutically acceptable salt, in, R1, R2, R3, R4 are the same or different and are independently selected from hydrogen, halogen, C1-C6 alkyl, halogenated C1-C6 alkyl, C1-C6 alkoxy, halogenated C1-C6 alkoxy, nitro or cyano; R5, R6, R7, R8 are the same or different and are independently selected from hydrogen, halogen, C1-C6 alkyl, halogenated C1-C6 alkyl, C1-C6 alkoxy or halogenated C1-C6 alkoxy; R9, R 10 are the same or different and are independently selected from hydrogen, halogen, hydroxy, cyano, C1-C6 alkyl, halogenated C1-C6 alkyl, C1-C6 alkoxy, halogenated C1-C6 alkoxy or -OR 13 ; R 13 is selected from C1-C6 alkenyl, C1-C6 alkynyl, C1-C6 alkoxy, C1-C6 alkyl, benzyl, C2-C4 acyl, halogenated C2-C4 acyl, benzoyl, C1-C6 alkylcarbamoyl or phenylcarbamoyl; R 11 , R 12 The same or different, independently selected from hydrogen, cyano, C1-C6 alkyl or halogenated C1-C6 alkyl, hydroxy C1-C4 alkyl.
2. The compound according to claim 1, its stereoisomer, racemate, tautomer, isotope-labeled substance, nitrogen oxide, pharmaceutically acceptable salt, solvate or solvate of a pharmaceutically acceptable salt, characterized in that: R1, R2, R3, R4 are the same or different and are independently selected from hydrogen, halogen, C1-C4 alkyl or halogenated C1-C4 alkyl, C1-C6 alkoxy, halogenated C1-C6 alkoxy, nitro or cyano; R5, R6, R7, R8 are the same or different and are independently selected from hydrogen, halogen, C1-C4 alkyl, halogenated C1-C4 alkyl, C1-C4 alkoxy or halogenated C1-C4 alkoxy; R9, R 10 are the same or different and are independently selected from hydrogen, halogen, hydroxyl, cyano, C1-C6 alkyl, halogenated C1-C6 alkyl, C1-C6 alkoxy or -OR 13 ; R 13 is selected from C1-C6 alkenyl, C1-C6 alkynyl, C1-C6 alkoxy, C1-C6 alkyl, benzyl, C2-C4 acyl, halogenated C2-C4 acyl, benzoyl or C1-C6 alkylcarbamoyl; R 11 , R 12 The same or different, independently selected from hydrogen, cyano, C1-C6 alkyl, halogenated C1-C6 alkyl, C1-C4 hydroxyalkyl.
3. The compound according to claim 1 or 2, its stereoisomer, racemate, tautomer, isotope-labeled substance, nitrogen oxide, pharmaceutically acceptable salt, solvate or solvate of a pharmaceutically acceptable salt, characterized in that: R1, R2, R3, R4 are the same or different and are independently selected from hydrogen, fluorine, chlorine, bromine, methyl, ethyl, trifluoromethyl or trifluoroethyl; R5, R6, R7, R8 are the same or different and are independently selected from hydrogen, fluorine, chlorine, bromine, methyl, ethyl, trifluoromethyl, trifluoroethyl, methoxy, ethoxy, trifluoromethoxy or trifluoroethoxy; R9, R 10 are the same or different and are independently selected from hydrogen, halogen, hydroxyl, cyano, C1-C6 alkyl, C1-C6 alkoxy or -OR 13 ; R 13 is selected from C1-C6 alkenyl, C1-C6 alkynyl, C1-C6 alkoxy, C1-C6 alkyl, benzyl, C2-C4 acyl, halogenated C2-C4 acyl or C1-C6 alkylcarbamoyl; R 11 , R 12 The same or different groups are independently selected from hydrogen, cyano, C1-C4 alkyl or hydroxy C1-C4 alkyl.
4. The compound according to any one of claims 1 to 3, its stereoisomer, racemate, tautomer, isotope-labeled substance, nitrogen oxide, pharmaceutically acceptable salt, solvate or solvate of a pharmaceutically acceptable salt, characterized in that: R1, R2, R3, R4 are the same or different and are independently selected from hydrogen, fluorine, chlorine, bromine, methyl, ethyl, trifluoromethyl or trifluoroethyl; R5, R6, R7, R8 are the same or different and are independently selected from hydrogen, fluorine, chlorine, bromine, methyl, ethyl, trifluoromethyl, trifluoroethyl, methoxy, ethoxy, trifluoromethoxy or trifluoroethoxy; R9, R 10 are the same or different and are independently selected from hydrogen, halogen, hydroxyl, cyano, C1-C6 alkyl, C1-C6 alkoxy or -OR 13 ; R 13 is selected from C1-C6 alkenyl, C1-C6 alkynyl, C1-C6 alkoxy, C1-C6 alkyl, benzyl, C2-C4 acyl or C1-C6 alkylcarbamoyl; R 11 , R 12 The same or different, are independently selected from hydrogen, cyano, C1-C4 alkyl, C1-C4 haloalkyl, hydroxy C1-C4 alkyl.
5. The compound according to any one of claims 1 to 4, its stereoisomer, racemate, tautomer, isotope-labeled substance, nitrogen oxide, pharmaceutically acceptable salt, solvate or solvate of a pharmaceutically acceptable salt, characterized in that: R1, R2, R3, R4 are the same or different and are independently selected from hydrogen, fluorine, chlorine, bromine, methyl or trifluoromethyl; R5, R6, R7, R8 are the same or different and are independently selected from hydrogen, fluorine, chlorine, bromine, methyl, trifluoromethyl, methoxy or trifluoromethoxy; R9, R 10 are the same or different and are independently selected from hydrogen, halogen, hydroxyl, cyano, C1-C6 alkyl, C1-C6 alkoxy or -OR 13 ; R 13 is selected from C1-C6 alkenyl, C1-C6 alkynyl, C1-C6 alkoxy, C1-C6 alkyl, benzyl, C2-C4 acyl or C1-C6 alkylcarbamoyl; R 11 , R 12 are the same or different and are independently selected from hydrogen, methyl, ethyl, propyl, isopropyl, butyl, hydroxymethyl or hydroxyethyl.
6. The compound according to any one of claims 1 to 5, its stereoisomer, racemate, tautomer, isotope-labeled substance, nitrogen oxide, pharmaceutically acceptable salt, solvate or solvate of a pharmaceutically acceptable salt, characterized in that: R1, R2, R3, R4 are the same or different and are independently selected from hydrogen, fluorine, chlorine, bromine or trifluoromethyl; R5, R6, R7, R8 are the same or different and are independently selected from hydrogen, fluorine, chlorine, bromine, methyl or trifluoromethyl; R9, R 10 are the same or different and are independently selected from hydrogen, fluorine, bromine, chlorine, hydroxyl, cyano, methyl, ethyl, methoxy, ethoxy, isopropoxy, tert-butoxy or -OR 13 ; R 13 Selected from cyclopropylmethyl, 2-propenyl, 2-butenyl, 2-propynyl, acetyl, chloroacetyl, benzoyl; R 11 , R 12 are the same or different and are independently selected from hydrogen, methyl, ethyl, propyl, isopropyl or hydroxymethyl; Preferably, R1 is hydrogen; R2 is trifluoromethyl; R3 is hydrogen; R4 is selected from hydrogen or chlorine; R5 is selected from hydrogen, fluorine, chlorine or bromine; R6 is hydrogen; R7 is selected from hydrogen, fluorine, chlorine or bromine; R8 is hydrogen; R9 is hydrogen; R 10 is selected from hydrogen, chlorine, bromine or methoxy; R 11 is methyl; R 12 Methyl, ethyl, hydroxymethyl; Preferably, the compound represented by formula (I) is selected from the compounds in Table 1 In the compounds of Table 1, when R1=H, R2=CF3, R3=H, R6=H, and R8=H, the other groups are as shown in the table; Table 1 7. A method for preparing the compound according to any one of claims 1 to 6, its stereoisomer, racemate, tautomer, isotope-labeled substance, nitrogen oxide, pharmaceutically acceptable salt, solvate or solvate of a pharmaceutically acceptable salt, comprising the following steps: The compound represented by formula (II) reacts with the compound represented by formula (III) to obtain the compound represented by formula (I); Among them, R1, R2, R3, R4, R5, R6, R7, R8, R9, R 10 , R 11 , R 12 The definition of any one of claims 1 to 6; L is selected from a leaving group, such as Cl or Br.
8. A pesticide composition comprising, as an active ingredient, one, two or more of the compound of formula (I) according to any one of claims 1 to 6, its stereoisomers, racemates, tautomers, isotope-labeled substances, nitrogen oxides, pharmaceutically acceptable salts, solvates or solvates of pharmaceutically acceptable salts; Preferably, the pesticide composition is a herbicidal composition; Preferably, the weight percentage of the active ingredient in the composition is 0.1-99.9%, for example 0.5-99%; Preferably, the composition can be administered in the form of a formulation; For example, the compound represented by formula (I) is dissolved or dispersed in a carrier as an active ingredient or formulated into a formulation so that it is easier to disperse when used as a weed killer; Preferably, the preparation includes but is not limited to the following forms: granules, wettable powders, oil suspensions, water suspensions, aqueous emulsions, aqueous preparations, emulsifiable concentrates or microcapsules, etc.; Preferably, a liquid or solid carrier and optionally a surfactant may also be added to the composition.
9. Use of one, two or more of the compound of formula (I) according to any one of claims 1 to 6, its stereoisomers, racemates, tautomers, isotope-labeled substances, nitrogen oxides, pharmaceutically acceptable salts or esters, solvates or solvates of pharmaceutically acceptable salts as pesticides, for example, for the preparation of growth regulators or herbicides.
10. A method for preventing and controlling harmful plants, comprising applying an effective amount of a compound of formula (I) as described in any one of claims 1 to 6, one, two or more of its stereoisomers, racemates, tautomers, isotope-labeled substances, nitrogen oxides, pharmaceutically acceptable salts or esters, solvates or solvates of pharmaceutically acceptable salts, or an effective amount of the pesticide composition as described in claim 7 to harmful plants, seeds or tubers of desired plants, or the growth area of desired plants.
